Search Results - "LONGO, W. L"

Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network by Kahl, BS, Longo, WL, Eickhoff, JC, Zehnder, J, Jones, C, Blank, J, McFarland, T, Bottner, W, Rezazedeh, H, Werndli, J, Bailey, HH

“…Background: There is no standard first line treatment for mantle cell lymphoma. Patients and methods: This was a multicenter phase II pilot study of rituximab…”
Get full text

Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation by RATANATHARATHORN, V, NASH, R. A, VAN DER JAGT, R, HERZIG, R. H, LITZOW, M. R, WOLFF, S. N, LONGO, W. L, PETERSEN, F. B, KARANES, C, AVALOS, B, STORB, R, BUELL, D. N, PRZEPIORKA, D, MAHER, R. M, FITZSIMMONS, W. E, WINGARD, J. R, DEVINE, S. M, KLEIN, J. L, WEISDORF, D, FAY, J. W, NADEMANEE, A, ANTIN, J. H, CHRISTIANSEN, N. P

“…We report the results of a phase III open-label, randomized, multicenter trial comparing tacrolimus/methotrexate to cyclosporine/methotrexate for…”
Get full text

A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa by MCCOY, A. G, SMITH, E. P, ATKINSON, M. E, BARANSKI, B, KAHL, B. S, JUCKETT, M, MITCHELL, T, GANGNON, R, LONGO, W. L

“…The purpose of this study was to evaluate the efficacy and toxicity of the preparative regimen of thiotepa and etoposide in patients undergoing autologous…”
Get full text

Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity by MINEISHI, S, LONGO, W. L, ATKINSON, M. E, SMITH, E. P, HAMIELEC, M, WIERSMA, S. R, KINSELLA, T. J, SCHUENING, F. G

“…The optimal conditioning regimen for allogeneic BMT for hematological malignancies is still to be determined. We used a conditioning regimen including…”
Get full text

Fludarabine and Cytarabine as a Sequential Infusion Regimen for Treatment of Adults with Recurrent, Refractory or Poor Prognosis Acute Leukemia by Vidarsson, Brynjar, Abonour, Rafat, Williams, Eliot C., Woodson, Robert D., Turman, Nancy J., Kim, Kyungmann, Mosher, Deane F., Wiersma, Susan R., Longo, Walter L.

“…We did a retrospective analysis on the safety and efficacy of sequential infusion fludarabine and cytosine arabinoside (ara-C) in treating refractory,…”
Get full text

Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide by McCroskey, R D, Mosher, D F, Spencer, C D, Prendergast, E, Longo, W L

“…Acute tumor lysis syndrome resulting from rapid neoplastic cell lysis after chemotherapy is an unusual event, generally seen in histological aggressive…”
Get more information

Cytomegalovirus-associated tubulointerstitial nephritis in an allogeneic bone marrow transplant recipient by Shorr, R I, Longo, W L, Oberley, T D, Bozdech, M J, Walker, D L

Get more information

Phase I trial of lonidamine with whole body hyperthermia in advanced cancer by ROBINS, H. I, LONGO, W. L, LAGONI, R. K, NEVILLE, A. J, HUGANDER, A, SCHMITT, C. L, RIGGS, C

“…Lonidamine is a dechlorinated derivative of indazole-3-carboxylic acid which preclinically synergizes with hyperthermia. Clinically, this nonmyelosuppressive…”
Get full text

Role of the spleen in the transdiaphragmatic spread of Hodgkin's disease by Mann, J L, Hafez, G R, Longo, W L

“…Results of detailed staging laparotomy for Hodgkin's disease with supradiaphragmatic presentation in 78 patients showed 28 with subdiaphragmatic involvement…”
Get more information

A pilot study of whole body hyperthermia and local irradiation for advanced non-small cell lung cancer confined to the thorax by Robins, H I, Longo, W L, Steeves, R A, Lagoni, R K, Hugander, A, Neville, A J, O'Keefe, S, Giese, W, Schmitt, C L

“…Six patients with Stage III non-small cell lung cancer completed therapy which consisted of 4 whole body hyperthermia (WBH) treatments during the first 2 weeks…”
Get more information

VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study by Chang, Julie E., Peterson, Christopher, Choi, Sangbum, Eickhoff, Jens C., Kim, KyungMann, Yang, David T., Gilbert, Leslie A., Rogers, Eric S., Werndli, Jae E., Huie, Michael S., McFarland, Thomas A., Volk, Michael, Blank, Jules, Callander, Natalie S., Longo, Walter L., Kahl, Brad S.

“…Summary Intensive chemotherapy regimens are not feasible in many adults with mantle cell lymphoma (MCL). We sought to build upon our previous experience with a…”
Get full text

Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease by Schuening, F, Longo, W L, Atkinson, M E, Zaboikin, M, Kiem, H P, Sanders, J, Scott, C R, Storb, R, Miller, A D, Reynolds, T, Bensinger, W, Rowley, S, Gooley, T, Darovsky, B, Appelbaum, F

Get more information

Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations by Robins, H I, Longo, W L, Steeves, R A, Cohen, J D, Schmitt, C L, Neville, A J, O'Keefe, S, Lagoni, R, Riggs, C

“…Based on earlier clinical and preclinical investigations, we designed two different pilot trials for patients with nodular lymphoma or chronic lymphocytic…”
Get more information

Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study by Chang, Julie E, Seo, Songwong, Kim, Kyungmann M, Werndli, Jae E, Bottner, Wayne A, Rodrigues, Gilberto A, Sanchez, Federico A, Saphner, Thomas J, Longo, Walter L, Kahl, Brad S

“…Abstract Purpose Human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) may potentiate rituximab activity by upregulating CD20 expression…”
Get full text

Trusteeship: shared mission for religious and laity by Longo, W L

“…Serving as a trustee requires commitment to a particular congregation's spirit or charism and to the health care apostolate. Vatican Council II urges that…”
Get more information

Phase II study of R-CHOP with GM-CSF cytokine support for elderly patients with untreated diffuse large B-cell lymphoma (DLBCL): A Wisconsin Oncology Network study by Kahl, B. S., Go, R. S., Rodrigues, G., Sanchez, F. A., Saphner, T. J., Werndli, J. E., Kirkpatrick, H. M., Longo, W. L.

“…Abstract only 7566 Background: According to mature data from the GELA study, approximately 55% of elderly patients with DLBCL will be cured with R-CHOP. We…”
Get full text

Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma by Fenske, Timothy S., Kahl, Brad S., Eickhoff, Jens, Mitchell, Teri L., Smith, Eileen P., Atkinson, Elizabeth, Mccoy, Alice Garry, Eckstein, Linda, Flynn, Bridget, Mcmannes, Jan, Howard, Steven, Longo, Walter L.

“…We recently described a novel thiotepa plus etoposide high-dose therapy (HDT) conditioning regimen for aggressive histology non-Hodgkin's lymphoma (NHL) that…”
Get full text